Also trades as: EW.SW (SIX)
EW NYSE
Edwards Lifesciences Corporation
1W: +3.8%
1M: +5.0%
3M: +8.2%
YTD: +6.1%
1Y: +18.3%
3Y: +31.1%
5Y: -18.5%
$90.82
+0.26 (+0.29%)
After Hours: $87.56 (-3.25, -3.58%)
Weekly Expected Move ±3.2%
$83
$86
$89
$92
$95
Credit Risk of going bust: lower than 96% of companies Debt: 1.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99.9%), Edwards Lifesciences Corporation would be worth roughly what it owes.
Total debt $704.4M against a stock market value of $52.20B.
Distance to default 20.45 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $299.4M (short-term plus half of long-term), stock volatility 25.5%; Altman Z 12.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.06 (down 99.9%), Edwards Lifesciences Corporation would be worth roughly what it owes.
Total debt $704.4M against a stock market value of $52.20B.
Distance to default 20.45 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $299.4M (short-term plus half of long-term), stock volatility 25.5%; Altman Z 12.73. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
2 neutral
0 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.67
Bullish
6 bullish
2 neutral
0 bearish
Articles (7d)
8
Daily Sentiment (7 Days)
Articles (100)
WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?
BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?
Is This the Right Time to Hold EW Stock in Your Portfolio?
Intuitive Surgical's Q3 Earnings Beat Estimates on Strong System Sales
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Edwards Lifesciences Corporation $EW Stock: Birch Hill Investment Advisors LLC Trims Position
First Citizens Bank & Trust Co. Makes New $792,000 Investment in Edwards Lifesciences Corporation $EW
Edwards Lifesciences Corporation $EW Stock: Assenagon Asset Management S.A. Boosts Stake
Bet on These Healthcare ETFs to Benefit From the Aging US Population
Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?
Edwards gains FDA approval of AUTUS pulmonary valve for pediatric patients
Find alpha in the revenue growth fog - Goldman
Andra AP fonden Boosts Stake in Edwards Lifesciences Corporation $EW
Stock index futures rise as investors focus on Trump-Xi summit
Baird Financial Group Inc. Has $11.79 Million Stake in Edwards Lifesciences Corporation $EW
Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement
Baron Asset Fund adds CBRS and EW; exits FICO and FND
Azimuth Capital Investment Management LLC Decreases Stock Position in Edwards Lifesciences Corporation $EW
Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
128,603 Shares in Edwards Lifesciences Corporation $EW Acquired by Beacon Pointe Advisors LLC
Bamco Inc. NY Makes New $20.77 Million Investment in Edwards Lifesciences Corporation $EW
Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?
MDT's Q1 Earnings on Deck: How Should You Play the Stock Now?
Bank of Nova Scotia Takes Position in Edwards Lifesciences Corporation $EW
37,702 Shares in Edwards Lifesciences Corporation $EW Bought by EP Wealth Advisors LLC
B. Metzler seel. Sohn & Co. AG Buys Shares of 41,753 Edwards Lifesciences Corporation $EW
Allworth Financial LP Takes Position in Edwards Lifesciences Corporation $EW
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
Should You Hold Edwards Lifesciences Stock in Your Portfolio?
BlackRock Inc. Acquires New Stake in Edwards Lifesciences Corporation $EW
BOK Financial Private Wealth Inc. Acquires Shares of 12,115 Edwards Lifesciences Corporation $EW
Baxter Bros Inc. Invests $3.54 Million in Edwards Lifesciences Corporation $EW
AMG National Trust Bank Invests $6.83 Million in Edwards Lifesciences Corporation $EW
Bank Hapoalim BM Makes New $1.78 Million Investment in Edwards Lifesciences Corporation $EW
Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?
Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation
Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?
Edwards Lifesciences Corporation $EW Stock Holdings Lessened by Glenmede Trust Co. NA
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises
Stock index futures edge higher as investors seek rebound after Thursday selloff
Edwards lifts 2026 sales growth outlook to 10%-11% while reaffirming $2.95-$3.05 EPS
Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Edwards Lifesciences Corporation $EW Shares Acquired by Andra AP fonden
Edwards' Q2 Earnings on the Horizon: What's in the Cards?
Boston Common Asset Management LLC Has $12.52 Million Stock Position in Edwards Lifesciences Corporation $EW
Notable healthcare headlines for the week: UnitedHealth, J&J, and Intuitive Surgical in focus
Earnings week ahead: GM, TSLA, GOOG, INTC, VZ, AMC, T, IBM, NOK, LMT, and more
Edwards Lifesciences Corporation $EW Shares Sold by Diversify Wealth Management LLC
HCA surgery volumes dip in Q2, sending MedTech stocks lower
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?
Here's How Macro Trends and Currency Headwind Restrict GMED's Growth
Notable healthcare headlines for the week: Merck, Moderna, and Biogen in focus
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device
Should You Continue to Hold EW Stock in Your Portfolio?
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth
Top Research Reports for Philip Morris, Honeywell & Starbucks
Arlington Trust Co LLC Lowers Position in Edwards Lifesciences Corporation $EW
AMG National Trust Bank Takes Position in Edwards Lifesciences Corporation $EW
Deltec Asset Management LLC Buys Shares of 6,000 Edwards Lifesciences Corporation $EW
Calamos Advisors LLC Has $13.90 Million Stake in Edwards Lifesciences Corporation $EW
Arizona State Retirement System Has $14.09 Million Stake in Edwards Lifesciences Corporation $EW
EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth
Edwards forecasts 9%-11% 2026 sales growth and $2.95-$3.05 adjusted EPS as TAVR guide rises to 7%-9%
Transcript: Edwards Lifesciences Q1 2026 Earnings Conference Call
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
Edwards Lifesciences Non-GAAP EPS of $0.78 beats by $0.05, revenue of $1.65B beats by $50M
Here are the major earnings after the close Monday
Earnings Scheduled For April 23, 2026
Boston Trust Walden Corp Sells 8,171 Shares of Edwards Lifesciences Corporation $EW
Fortis Capital Advisors LLC Buys Shares of 10,468 Edwards Lifesciences Corporation $EW
Edwards Lifesciences' Q1 Earnings on Deck: Here's What to Expect
Mirae Asset Global Investments Co. Ltd. Increases Holdings in Edwards Lifesciences Corporation $EW
Asset Management One Co. Ltd. Raises Holdings in Edwards Lifesciences Corporation $EW
Birch Hill Investment Advisors LLC Sells 13,385 Shares of Edwards Lifesciences Corporation $EW
Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?
Top Stock Reports for Eli Lilly, Mastercard & AMD
Notable healthcare headlines for the week: Organon, Eli Lilly, and Gilead in focus
Edwards Lifesciences Corporation $EW Shares Bought by Allspring Global Investments Holdings LLC
Boston Common Asset Management LLC Acquires 9,028 Shares of Edwards Lifesciences Corporation $EW
Amiral Gestion Has $19.33 Million Stock Holdings in Edwards Lifesciences Corporation $EW
Cullen Investment Group LTD. Has $744,000 Holdings in Edwards Lifesciences Corporation $EW
Edwards Lifesciences Corporation $EW Shares Acquired by Assenagon Asset Management S.A.
Citi's top large-cap stocks with positive ROE trends
Central Pacific Bank Trust Division Buys New Holdings in Edwards Lifesciences Corporation $EW
CIBC Private Wealth Group LLC Has $7.43 Million Stake in Edwards Lifesciences Corporation $EW
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?
AIA Group Ltd Sells 314,688 Shares of Edwards Lifesciences Corporation $EW
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?